Home › Kanser sa Atay (Hepatocellular Carcinoma) › Texas › Houston
Pag-aaral pangklinika para sa Kanser sa Atay (Hepatocellular Carcinoma) sa Houston, TX
Isang pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of ZW251 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC
Nagre-recruitPhase 1/2
- Research Facility, Houston
National Liver Cancer Screening Trial
Nagre-recruitPhase 4
- Baylor College of Medicine, Houston
A Phase 1/2 Study of BGB-B2033, Alone or in Combination With Tislelizumab With or Without Bevacizumab, in Participants With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- The University of Texas Md Anderson Cancer Center, Houston
Nivolumab, Fluorouracil, and Interferon Alpha 2B for the Treatment of Unresectable Fibrolamellar Cancer
Nagre-recruitPhase 1/2
- M D Anderson Cancer Center, Houston
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Nagre-recruitPhase 3
- Research Site, Houston
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
Nagre-recruitPhase 1/2
- Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston
FOG-001 in Locally Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
Nagre-recruitPhase 1/2
- Research Site, Houston
A Study of MGC026 in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
- University of Texas Health Science Center at Houston, Houston
IDOV-Immune for Advanced Solid Tumors
Nagre-recruitPhase 1
- MD Anderson Cancer Center, Houston
A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
Nagre-recruitPhase 2
- University of Texas MD Anderson Cancer Center, Houston
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
Nagre-recruitPhase 1
- The University of Texas MD Anderson Cancer Center Investigational Pharmacy Services, Houston
- The University of Texas MD Anderson Cancer Center, Houston
Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax
Nagre-recruitPhase 1
- M D Anderson Cancer Center, Houston
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Nagre-recruitPhase 1
- Clinical Trial Site, Houston
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Nagre-recruit
- Michael E. DeBakey VA Medical Center, Houston, TX, Houston
A Trial Utilizing 18F-FS PG PET to Guide Therapy in Hepatocellular Carcinoma
Nagre-recruitPhase 1
- The University of Texas M. D. Anderson Cancer Center, Houston
A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
Nagre-recruitPhase 1
- The University of Texas MD Anderson Cancer Center, Houston
Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy
Nagre-recruitPhase 2
- M D Anderson Cancer Center, Houston
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
Nagre-recruit
- M D Anderson Cancer Center, Houston
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Nagre-recruitPhase 2
- USA12-0, Houston
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
Nagre-recruitPhase 1/2
- University of Texas MD Anderson Cancer Center, Houston
Impact of "Teaching the Teachers" Concept on Global Education and Application of Hepatocellular Carcinoma Diagnosis Guidelines
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
- M D Anderson Cancer Center, Houston
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Nagre-recruitPhase 1/2
- MD Anderson Cancer Center, Houston
Study of RP2 in Combination With Second-line Therapy in Patients With Locally Advanced or Metastatic HCC
Nagre-recruitPhase 2
- Houston Methodist Hospital Cancer Center, Houston
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Nagre-recruitPhase 1
- Oncology Consultants, Houston
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Nagre-recruitPhase 2
- Baylor College of Medicine, Houston
Zanzalintinib (XL-092) Plus Durvalumab and Tremelimumab in Unresectable Hepatocellular Carcinoma (ZENOBIA)
Nagre-recruitPhase 2
- Houston Methodist Neal Cancer Center, Houston
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Nagre-recruitPhase 1
- Houston Methodist Hospital, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Nagre-recruitObservasyonal na pag-aaral
- Massive Bio SYNERGY-AI site, Houston
Atezolizumab and Bevacizumab Pre-Liver Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria
Nagre-recruitPhase 4
- Houston Methodist Research Institute, Houston
Pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) sa ibang lungsod
- New York City, NY24 pag-aaral
- Dallas, TX19 pag-aaral
- Los Angeles, CA19 pag-aaral
- Boston, MA18 pag-aaral
- Cleveland, OH18 pag-aaral
- Philadelphia, PA16 pag-aaral
- Chicago, IL16 pag-aaral
- Pittsburgh, PA15 pag-aaral
- San Francisco, CA14 pag-aaral
- Orange, CA14 pag-aaral
- Jacksonville, FL14 pag-aaral
- San Antonio, TX13 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer145 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)121 pag-aaral
- Metastatic Cancer104 pag-aaral
- Colorectal Cancer102 pag-aaral
- Kanser sa Ovary89 pag-aaral
- Acute Myeloid Leukemia85 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate76 pag-aaral
- Kanser ng Endometrium68 pag-aaral
- Kanser sa Pancreas61 pag-aaral
- Melanoma59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.